Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Patient Square Capital LP

Q2 2023 · 13F-HR

Patient Square Capital LPholdings as filed

Filed 2023-08-11 · accession 0000950123-23-007492

$205.4M
Reported value
2
Positions
2023-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
G76279101ROIVROIVANT SCIENCES LTD$127.4M62.0%12,639,920CommonSOLE
270087208EARGO INC$78.0M38.0%15,821,299CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.